SIGNA MAGNUS

by GE HealthCare  · Based in United States → — Explore the brain in exceptionally high detail.
Neurology Neurosurgery Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact vendor for pricing
Regulatory Status Disclosed

Overview

GE HealthCare’s SIGNA™ MAGNUS is a groundbreaking 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. Designed specifically for advanced neuroimaging, it pushes the boundaries of neurological research and clinical diagnostics. The system features innovative HyperG gradient technology, delivering exceptional power (300 mT/m, 750 T/m/s) and an asymmetric gradient design for enhanced diffusion performance, allowing for ultra-high detail visualization of brain function, microstructures, and microvasculature. SIGNA MAGNUS integrates deep-learning algorithms, such as AIR™ Recon DL, to amplify its advanced hardware capabilities, providing pin-sharp precision and clarity in images. It aims to uncover new parameters, areas of research, and biomarkers, translating clinical discoveries into practice for neurological, oncological, and psychiatric conditions.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Head-only 3.0T MRI scanner
  • HyperG gradient technology (300 mT/m, 750 T/m/s)
  • Enhanced diffusion performance with high b-values (e.g., up to 30,000 and beyond)
  • AI-amplified capabilities, including AIRu2122 Recon DL
  • Innovative asymmetric gradient coil design
  • Ultra-high anatomical resolution and image clarity
  • Short scan times for improved patient comfort and efficiency
  • ODEN (Oscillating Diffusion ENcoding) for exploring brain function, microstructures, and microvasculature
  • Potential for new biomarker discovery and advanced research
  • Available as a new system installation or an upgrade for compatible GE HealthCare 3.0T whole-body scanners

Use Cases

  • Advanced neuroimaging for detailed brain visualization
  • Neurological research, including neurodegenerative diseases and psychiatric conditions
  • Oncological imaging of the brain
  • Detection and diagnosis of neurological, oncological, and psychiatric conditions
  • Biomarker discovery and development
  • In-depth exploration of brain microstructure, microvasculature, and function

What Physicians Need to Know

Stroke Detection Support
SIGNA MAGNUS facilitates faster image acquisition and short scan times, crucial for rapid assessment in stroke cases. Its high-resolution imaging, enhanced by deep-learning algorithms, provides detailed anatomical and diffusion information vital for timely diagnosis. [3, 10, 11, 14, 16, 17, 20]
Brain MRI Analysis
The system offers ultra-high detail brain visualization using powerful HyperG gradients and integrates GE HealthCare's latest deep-learning algorithms, including AIRu2122 Recon DL, for pin-sharp precision. It enables in-depth exploration of brain function, microstructures, and microvasculature through techniques like ODEN (Oscillating Diffusion ENcoding). [1, 2, 4, 5, 8, 10, 11, 14, 15, 19, 23, 25]
Neurodegenerative Disease Screening
SIGNA MAGNUS is designed to advance research and clinical understanding of neurodegenerative diseases, psychiatric conditions, and brain health. Amplified by deep-learning algorithms, it supports the exploration of new biomarkers and provides detailed visualization essential for early detection and monitoring of these complex disorders. [3, 4, 5, 6, 7, 8, 10, 11, 14, 15, 19, 23, 25]
Large Vessel Occlusion Detection Support
The system's advanced diffusion performance, high B-value diffusion imaging, and ability to visualize microvasculature and neurovascular details with short echo times are critical for identifying large vessel occlusions. [2, 10, 11, 14, 15, 18]
Physician Tip

Leverage SIGNA MAGNUS's exceptional gradient performance and deep-learning capabilities, particularly AIRu2122 Recon DL and ODEN, to uncover subtle brain microstructures and microvasculature previously undetectable. Utilize the faster scan times for improved patient comfort and workflow efficiency, especially for challenging neurological cases. Focus on its advanced diffusion and functional imaging for biomarker discovery and a deeper understanding of neurodegenerative and oncological conditions. The high-resolution output will significantly enhance diagnostic confidence and research potential.

SIGNA MAGNUS seamlessly integrates GE HealthCare's deep-learning algorithms and is designed as an open platform to foster collaboration with a network of neuroscientists. Many existing GE HealthCare 3.0T systems are upgradable to SIGNA MAGNUS, allowing facilities to enhance their neuroimaging capabilities without requiring entirely new infrastructure. [1, 2, 4, 8, 10, 14, 19, 23, 25]

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact vendor for pricing
DeploymentOn-premise (physical medical equipment installation)
Compliance
BAA Available Yes AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

FDA 510(k) clearance (K241242) was received on October 17, 2024, for SIGNA MAGNUS. It is indicated for use as a diagnostic imaging device to produce images, spectroscopic images, parametric maps, and/or spectra, dynamic images of the structures and/or functions of the head, neck, TMJ, and limited cervical spine on patients 6 years of age and older.
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

What the Web Says

The GE HealthCare SIGNA MAGNUS is a 3.0T head-only MRI system specifically designed for advanced neuroimaging, cleared by the FDA in November 2024. It aims to provide highly detailed images of the brain and central nervous system, offering new capabilities for clinical imaging and neuroscience research. The system is praised for its innovative asymmetrical gradient coil technology, HyperG, which allows for superior gradient performance, faster image acquisition, and enhanced image clarity.

Overall: Positive

Strengths

  • Exceptional precision and ultra-high anatomical resolution for neuroimaging.
  • Faster image acquisition and shorter scan times, beneficial for patients with claustrophobia or difficulty remaining still.
  • Advanced diffusion techniques and high signal-to-noise ratio imaging.
  • Potential to uncover new biomarkers and advance research in neurodegenerative diseases and psychiatric conditions.
  • Innovative asymmetrical HyperG gradient coil design for superior performance.
  • Upgradability for many existing GE HealthCare 3.0T systems, potentially saving capital costs.

Limitations

  • As a specialized head-only MRI, its utility is limited to neuroimaging and cannot be used for whole-body scans.
  • Limited information available from independent tech reviewers, Reddit, G2, or Capterra specifically for the GE Healthcare SIGNA MAGNUS, as many search results refer to other 'Magnus' products (e.g., Secretlab Magnus desk, Magnus Health software).
  • The system is relatively new to the market, having received FDA clearance in late 2024, so long-term user reviews from a broad base of physicians are still emerging.

Based on reviews from: Xtalks, GE HealthCare, Applied Radiology, Medical Product Outsourcing, Diagnostic Imaging, MedTech Dive

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate SIGNA MAGNUS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

GE HealthCare
GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
GE HealthCare received FDA 510(k) clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only MRI scanner, designed to advance neuroimaging and aid in detecting neurological, oncological, and psychiatric conditions.
2024-11
Interventional News
GE Healthcare receives US FDA 510(k) clearance for Signa Magnus MRI scanner
GE HealthCare announced FDA 510(k) clearance for its Signa Magnus MRI scanner, a 3-tesla head-only system aimed at improving clinical imaging and neuroscience research for various conditions.
2024-11
Medical Product Outsourcing
FDA OKs GE HealthCare's Head-Only Signa Magnus 3T MRI - Medical Product Outsourcing
GE HealthCare's Signa Magnus 3T, a head-only MRI system, has received FDA 510(k) clearance, offering new capabilities for clinical imaging and neuroscience with potential to aid in detecting neurological, oncological, and psychiatric conditions.
2024-11
AuntMinnie
FDA clears GEHC's Signa Magnus MRI scanner - AuntMinnie
GE HealthCare has received U.S. Food and Drug Administration (FDA) clearance for its head-only 3-tesla MRI scanner, Signa Magnus.
2024-11
Imaging Technology News (ITN)
GE HealthCare Unveils Head-Only MR Scanner Toward Neuroscience Advancements
GE HealthCare unveiled its SIGNA MAGNUS, an FDA 510(k) pending head-only MR scanner, at ISMRM 2024, designed to advance neuroscience research previously limited by conventional whole-body MR systems.
2024-05
GE HealthCare
Pushing the Boundaries of Neuroscience with GE HealthCare's SIGNA MAGNUS
GE HealthCare unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only MR scanner, aiming to expand neuroscience research in neurology, oncology, and psychiatry, overcoming limitations of conventional whole-body MR systems.
2024-05
Medical Device Network
GE HealthCare unveils SIGNA MAGNUS for advanced neuroscience
GE HealthCare introduced SIGNA MAGNUS, a high-performance, head-only MR scanner tailored for advanced imaging in neurology, oncology, and psychiatry, currently pending FDA 510(k) clearance.
2024-05
GE HealthCare
High-performance gradients for advanced neuroimaging - SIGNA Pulse - GE HealthCare
This article highlights the strengths and advantages of GE HealthCare's SIGNA MAGNUS 3.0T MR system, which received U.S. FDA clearance in November 2024, for advanced neuroimaging applications.
2024-11

Videos

Product demos, reviews, and walkthroughs for SIGNA MAGNUS.

View all on YouTube

Frequently Asked Questions

SIGNA MAGNUS integrates deep-learning AI algorithms, such as AIRu2122 Recon DL, to amplify its advanced hardware capabilities, providing pin-sharp precision and ultra-high detail in brain imaging. This allows physicians to visualize microstructures and microvasculature previously unseen, aiding in the exploration of brain function and potential biomarker discovery for neurological, oncological, and psychiatric conditions.
SIGNA MAGNUS has received FDA 510(k) clearance in the United States, validating its safety and effectiveness for clinical use. As a GE HealthCare product, it adheres to stringent healthcare data privacy standards, though specific details on AI data handling would require direct inquiry with the vendor to ensure HIPAA and other regulatory compliance.
SIGNA MAGNUS is a dedicated 3.0T head-only MRI scanner featuring powerful HyperG gradient technology (300 mT/m, 750 T/m/s) and an innovative asymmetric gradient design. This specialized design allows for superior gradient performance, ultra-high b-value diffusion, and shorter scan times, surpassing the capabilities of conventional whole-body MRI systems for intricate neuroimaging.
The primary limitation of SIGNA MAGNUS is its dedicated head-only design, meaning it cannot be used for imaging other body parts. While its AI enhances neuroimaging, like all AI in healthcare, its capabilities are specific to the tasks it's trained for and should always be used in conjunction with physician expertise for diagnosis and treatment planning.
Specific pricing for SIGNA MAGNUS is not publicly disclosed and typically requires direct consultation with GE HealthCare. However, as a high-performance, specialized 3.0T MRI system, it represents a significant capital investment, with ongoing costs for maintenance, software updates, and potential service contracts, though many existing GE HealthCare 3.0T systems are upgradable to MAGNUS, potentially reducing initial capital outlay.
The deep-learning AI in SIGNA MAGNUS, such as AIRu2122 Recon DL, significantly improves image quality by reducing noise and artifacts, leading to higher resolution and clearer images. This enhanced clarity can improve diagnostic accuracy by revealing finer details and also contributes to workflow efficiency through faster image acquisition and potentially shorter scan times.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from GE HealthCare

AI Orchestrator
GE HealthCare
Practice Management & Scheduling
GE HealthCare's AI Orchestrator integrates and manages AI applications within a healthcare imaging ecosystem to streamline workflows and improve diagnostic accuracy.
Contact for pricing
Aurora
GE HealthCare
Oncology AI
GE HealthCare's Aurora is an AI-powered dual-head SPECT/CT system designed to enhance diagnostic capabilities and streamline workflows in nuclear medicine, offering excellent image quality and operational efficiency for various clinical applications.
N/a
Centricity Universal Viewer
GE Healthcare
Radiology & Imaging AI
GE Healthcare's Centricity Universal Viewer is a web-based PACS with AI-powered tools, advanced visualization, and multi-modality support to enhance diagnostic confidence and streamline clinical workflows for radiologists and specialists.
Contact vendor
Command Center
GE HealthCare
Practice Analytics & BI
GE HealthCare's Command Center is an AI-powered platform that optimizes hospital operations and patient flow through real-time visibility and predictive analytics.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.